ROCHE REGISTRATION GMBH
ItalyAll medications by this manufacturer
-
Alecensa
Form: capsules, hard gelatin
Active substance Dosage ALECTINIB — ATC: L01ED03
-
Avastin
Form: solution for infusion, concentrate
Active substance Dosage BEVACIZUMAB — ATC: L01FG01
-
CellCept
Form: capsules, hard gelatin
Active substance Dosage MYCOPHENOLATE MOFETIL — ATC: L04AA06
-
Columvi
Form: solution for infusion, concentrate
Active substance Dosage GLOFITAMAB — ATC: L01FX28
-
Cotelllic
Form: tablets, film-coated
Active substance Dosage COBIMETINIB — ATC: L01EE02
-
Enspryng
Form: solution for injection
Active substance Dosage SATRALIZUMAB — ATC: L04AC19
-
Erivedge
Form: capsules, hard gelatin
Active substance Dosage VISMODEGIB — ATC: L01XJ01
-
Es briet
Form: capsules, hard gelatin
Active substance Dosage PIRFENIDONE — ATC: L04AX05
-
Evrysdi
Form: powder for oral solution
Active substance Dosage RISDIPLAM — ATC: M09AX10
-
Fuzeon
Form: solution for injection, powder and solvent
Active substance Dosage ENFUVIRTIDE — ATC: J05AX07
-
Gazyvaro
Form: solution for infusion, concentrate
Active substance Dosage OBINUTUZUMAB — ATC: L01FA03
-
Hemlibra
Form: solution for injection
Active substance Dosage EMICIZUMAB — ATC: B02BX06
-
Herceptin
Form: powder for concentrate for infusion solution
Active substance Dosage TRASTUZUMAB — ATC: L01FD01
-
Itovebi
Form: tablets, film-coated
Active substance Dosage INAVOLISIB — ATC: L
-
Kadcyla
Form: solution for infusion, powder for preparation
Active substance Dosage TRASTUZUMAB EMTANSINE — ATC: L01FD03
-
Lunsumio
Form: solution for injection for infusion concentrate
Active substance Dosage MOSUNETUZUMAB — ATC: L01FX25
-
MabThera
Form: solution for injection
Active substance Dosage RITUXIMAB — ATC: L01FA01
-
Mircera
Form: solution for injection
Active substance Dosage Methoxypolyethylene glycol-epoetin beta (CERA) — ATC: B03XA03
-
Neorecormon
Form: solution for injection, powder and solvent
Active substance Dosage EPOETIN BETA — ATC: B03XA01
-
Ocrevus
Form: solution for infusion, concentrate
Active substance Dosage OCRELIZUMAB — ATC: L04AG08
-
Perjeta
Form: solution for infusion, concentrate
Active substance Dosage PERTUZUMAB — ATC: L01FD02
-
Phesgo
Form: solution for injection
Active substance Dosage PERTUZUMAB — TRASTUZUMAB — ATC: L01FY01
-
Piasky
Form: solution for injection or infusion
Active substance Dosage CROVALIMAB — ATC: L04AJ07
-
Polivy
Form: powder for concentrate for infusion solution
Active substance Dosage POLATUZUMAB VEDOTIN — ATC: L01FX14
-
RoActemra
Form: solution for infusion, concentrate
Active substance Dosage TOCILIZUMAB — ATC: L04AC07
-
Rozlytrek
Form: capsules, hard gelatin
Active substance Dosage ENTRECTINIB — ATC: L01EX14
-
Tamiflu
Form: capsules, hard gelatin
Active substance Dosage OSELTAMIVIR — ATC: J05AH02
-
Tecentriq
Form: solution for infusion, concentrate
Active substance Dosage ATEZOLIZUMAB — ATC: L01FF05
-
Vabysmo
Form: solution for injection
Active substance Dosage FARICIMAB — ATC: S01LA09
-
Xofluza
Form: tablets, film-coated
Active substance Dosage BALOXAVIR MARBOXIL — ATC: J05AX25
-
Zelboraf
Form: tablets, film-coated
Active substance Dosage VEMURAFENIB — ATC: L01EC01